Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients

Subarachnoid Hemorrhage Clinical Trial

Official title:

The Possible Role of Neuropeptide Y After Spontaneous Subarachnoid Hemorrhage

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01292278
• Other study ID #: CSF 06/179
• Status: Recruiting
• Phase: N/A
• First received: February 8, 2011
• Last updated: December 4, 2014
• Start date: January 2006
• Est. completion date: December 2016

Study information

• Verified date: December 2014
• Source: University of Regensburg
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: The Bavarian State Ministry of the Environment and Public Health
• Study type: Observational

Clinical Trial Summary

Neuropeptide Y (NPY) may play a major role in the pathophysiology of aneurysmal subarachnoid hemorrhage (aSAH). To investigate the correlation of NPY in cerebrospinal fluid (CSF) and blood (serum) and the neurological outcome in the acute stage of aSAH.

Description:

Evaluation of Neuropeptides in CSF and serum in SAH patients

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 90
• Est. completion date: December 2016
• Est. primary completion date: August 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• spontaneous or aneurysmal subarachnoid hemorrhage

Exclusion Criteria:

• age younger than 18 years or older than 70 years

• inflammatory disease

• history of former SAH

• no ventricular drainage

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Hemorrhage
• Subarachnoid Hemorrhage

Locations

Country	Name	City	State
Germany	Department of Neurosurgery Medical Center University of Regensburg	Regensburg

Sponsors (2)

Lead Sponsor	Collaborator
University of Regensburg	Technische Universität München

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Glasgow Outcome Scale		2011-2016	No